FINCH THERAPEUTICS GROUP INC (FNCH) Stock Income Statement
NASDAQ:FNCH - Nasdaq - US31773D2009 - Common Stock - Currency: USD
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 107.00K | 860.00K | 18.53M | 7.72M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | 0.00 | |||
| Gross Profit | N/A | N/A | N/A | N/A | 7.72M | |||
| Operating Expenses | 22.66M | 34.11M | 95.98M | 78.52M | 47.16M | |||
| Research and Development | 200.00K | 7.20M | 57.89M | 57.28M | 33.14M | |||
| Selling, General, and Administrative Expenses | 22.46M | 26.91M | 38.09M | 21.24M | 14.01M | |||
| Operating Income | -22.66M | -34.00M | -95.12M | -59.99M | -39.44M | |||
| Interest Income/Expense | 1.42M | 1.57M | 250.00K | 20.00K | 110.00K | |||
| Other Income/Expense | 4.05M | 4.05M | 700.00K | -50.00K | 0.00 | |||
| Non Recurring Items | 131.00K | -50.47M | -20.47M | 1.83M | N/A | |||
| Income Before Taxes | -16.29M | -78.22M | -114.65M | -58.16M | -39.34M | |||
| Income Tax | 0.00 | -3.46M | 0.00 | 0.00 | 0.00 | |||
| Net Income | -16.29M | -74.75M | -114.65M | -58.16M | -39.34M | |||
| EBITDA | -22.46M | -32.48M | -89.61M | -57.69M | -38.65M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.15 | -46.59 | -72.12 | -44.39 | -25.04 | |||
| Non GAAP EPS | N/A | N/A | N/A | -13.53 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | 100.00% | |||
| Profit Margin | N/A | -69863.55% | -13331.40% | -313.87% | -509.59% | |||
| Operating Profit Margin | N/A | -31777.57% | -11060.47% | -323.75% | -510.88% | |||
All data in USD